Syringe Access

Increasing sterile syringe access through syringe exchange programs and non-prescription pharmacy sales is essential to reducing syringe sharing among injection drug users and decreasing rates of HIV/AIDS and hepatitis C transmission.  Syringe exchange programs have also been shown to increase the safe disposal of used syringes, protecting police officers and the public from accidental exposure to blood-borne diseases.  Despite the benefits of these life-saving programs, legal and bureaucratic barriers still prevent injection drug users from accessing clean syringes. The Drug Policy Alliance has led efforts to increase syringe access in several states and is playing a key role in repealing the federal syringe funding ban.  We continue to push for reforms that would greatly reduce rates of disease transmission, overdose and other risks associated with injection drug use.
 

New Jersey Senate Health, Human Services and Senior Citizens Committee to Vote on Sterile Syringe Access Legislation to Prevent the Spread of HIV/AIDS

Committee Scheduled for Thursday, January 20, 1 p.m.; Bill Would Allow Over-the-Counter Sale of Limited Numbers of Syringes in Pharmacies

Public Health, and HIV Prevention Advocates Urge Passage of Life-Saving Legislation

Trenton—On Thursday, January 20, the New Jersey Senate Health, Human Services and Senior Citizens Committee will consider life-saving legislation to allow for the sale of limited numbers of syringes in pharmacies without a prescription. The hearing will be held at 1 p.m. in Committee Room 1 on the first floor of the statehouse annex. New Jersey is one of only two states (the other state is Delaware) that completely ban over-the-counter sale of syringes.

Tony Newman at 646-335-5384 or Roseanne Scotti at 609-610-8243

Congress Repeals Decades-Old National Syringe Funding Ban and Allows Washington, D.C. to Establish a Medical Marijuana Program

States Could Use Federal Money to Distribute Sterile Syringes to Reduce HIV/AIDS and Hepatitis C as Soon as Obama Signs the Bill into Law; Washington, D.C. Could Join 13 States in Allowing Patients to Grow and Use Marijuana for Medical Use
Reforms Part of Growing Momentum in Support of Ending the Failed War on Drugs

Bill Piper at 202-669-6430

Access to Sterile Syringes and Public Health Costs in New Jersey: Suggestions for Public Policy

November 1, 2003
Donald M. Scarry, J.D., Ph.D.
Commissioned by the Drug Policy Alliance

This report highlights the connections between New Jersey's restrictive distribution scheme for sterile syringes and the incidence of HIV/AIDS and Hepatitis C among injection drug users. The recommendation we offer in this report is simple and straightforward: Any steps New Jersey can take to increase access to sterile syringes should be immediately incorporated into a strong, aggressive public health strategy to combat injection drug use.

Campaign for a Healthier New Jersey Supporters

American Diabetes Association

Garden State Association of Diabetes Educators

Diabetes Foundation, Inc.

Hepatitis C Association

Medical Society of New Jersey

New Jersey Hospital Association

New Jersey State Nurses Association

Hyacinth AIDS Foundation

Black Ministers Council of New Jersey

New Jersey Academy of Family Physicians

AIDS Resource Foundation for Children

National Association of Social Workers-NJ Chapter

Garden State Pharmacy Owners

New Jersey Council of Chain Drug Stores

Every Life Matters

A young woman struggles to cope with the death of her father, who was infected with AIDS as a result of injection drug use.

Read Michele's story.

Harm Reduction: Evidence, Impacts and Challenges

April 20, 2010
EMCDDA

This volume includes a variety of perspectives on harm reduction approaches, together with an analysis of the concept's role within drug policies, both in Europe and beyond. Readers may not necessarily agree with all of the arguments made or the conclusiondrawn, but we hope it is perceived as a valuable contribution to the ongoing debate on how to respond to contemporary drug problems in Europe.

The International Centre for Science in Drug Policy

The International Centre for Science in Drug Policy (ICSDP) is an international network of scientists, academics, and health practitioners committed to improving the health and safety of communities and individuals affected by illicit drugs.

YouthRise

Youth R.I.S.E. (Resource. Information. Support. Education) is an international, youth-led network of young people committed to confronting the reality that young people today live in a world where drugs are more accessible on the street than the education and resources needed to reduce their harm.

Chicago Recovery Alliance

The Chicago Recovery Alliance (CRA) is an ethnically diverse group composed of people living with HIV and drug use, working in addiction treatment, health care, education, law and assorted other areas. CRA is unique as an organization in that the community of individuals affected by HIV and drug use is primarily involved in consuming drugs and support around living with HIV. CRA is an action organization for those interested in directly serving, supporting, educating and advocating with others for reducing drug-related harms.

Four Pillars Strategy

Vancouver's Four Pillars Drug Strategy is a coordinated, comprehensive approach to drug addiction that balances public order and public health in order to create a safer, healthier community.

Page 6 of 7
Syndicate content